Voluntary Announcement First Subject Enrolled in International Multi-Center Phase 3 Clinical Study of Denosumab

Boan Biotech Releases Its First ESG Report, Shouldering ESG Responsibilities and Pursuing High-quality Development

Recently, Boan Biotech published its first Environmental, Social and Governance Report (“ESG Report”). Responding to internal and external stakeholders’ focuses and concerns on company develop...

Form of Proxy for Use at Annual General Meeting to be Held on 29 May 2023 (Applicable to Holders of H Shares)

Notice of Annual General Meeting

(1) 2022 Report of the Board of Directors (2) 2022 Report of the Board of Supervisors (3) 2022 Annual Report (4) Re-Appointment of Auditor (5) Remuneration of Directors (6) Remuneration of Supervisors (7) General Mandate to Issue Additional Shares (8) Pro

2022 Environmental, Social and Governance Report

Annual Report 2022

Annual Report 2022

Proposed Amendments to the Articles of Association

Removal of Stock Marker